Ascension Asset Management’s ResMed RMD Stock Holding History

Ascension Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.36M	Hold	7,115	–	–	0.71%	52
2024 Q1	$1.41M	Buy	+7,115	New	+$1.3M	0.76%	54
2023 Q2	$3.19M	Buy	+14,586	New	+$3.25M	1.95%	11
2022 Q4	$3.04M	Sell	14,586 -25	-0.2%	-$5.49K	2.19%	7
2022 Q3	$3.18M	Hold	14,611	–	–	2.5%	7
2022 Q2	$3.06M	Buy	+14,611	New	+$3.11M	2.26%	7
2021 Q4	$3.84M	Sell	14,752 -200	-1%	-$51.9K	2.28%	10
2021 Q3	$3.94M	Hold	14,952	–	–	2.58%	8
2021 Q2	$3.69M	Sell	14,952 -250	-2%	-$52.6K	2.41%	9
2021 Q1	$2.95M	Buy	+15,202	New	+$3.05M	2.07%	11
2020 Q4	–	Sell	-15,727	Closed	-$2.7M	–	86
2020 Q3	$2.7M	Buy	+15,727	New	+$2.9M	2.16%	11
2020 Q1	$2.33M	Buy	15,785 +100	+0.6%	+$15.9K	2.41%	7
2019 Q4	$2.43M	Hold	15,685	–	–	2.1%	11
2019 Q3	$2.12M	Sell	15,685 -1,275	-8%	-$167K	1.96%	16
2019 Q2	$2.07M	Hold	16,960	–	–	1.82%	17
2019 Q1	$1.76M	Sell	16,960 -200	-1%	-$20.6K	1.58%	24
2018 Q4	$1.95M	Hold	17,160	–	–	1.98%	14
2018 Q3	$1.98M	Buy	17,160 +60	+0.4%	+$6.57K	1.74%	18
2018 Q2	$1.77M	Buy	17,100 +650	+4%	+$65.8K	1.62%	26
2018 Q1	$1.62M	Hold	16,450	–	–	1.48%	27
2017 Q4	$1.39M	Buy	+16,450	New	+$1.36M	1.27%	34

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ascension Asset Management's RMD Position: Q2 2024 in Review

Ascension Asset Management held its ResMed (RMD) position steady in Q2 2024 at 7,115 shares worth $1.36M. The position accounts for 0.71% of the portfolio, ranked #52.

Ascension Asset Management first reported a position in RMD in Q4 2017 and has held it in 21 quarters since. The position peaked at $3.94M in Q3 2021. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

Ascension Asset Management held 7,115 shares of ResMed worth $1.36M as of Q2 2024.
Ascension Asset Management left its ResMed share count unchanged in Q2 2024.
ResMed made up 0.71% of Ascension Asset Management's portfolio in Q2 2024, its #52 holding.
Ascension Asset Management first reported a position in ResMed in Q4 2017 and has held it in 21 quarters since.
Ascension Asset Management's ResMed position peaked at $3.94M in Q3 2021.
771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Ascension Asset Management's 13F filing for Q2 2024, filed 16 Aug 2024.